Neurotech International Ltd
Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company focuses on development and commercialization of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxati… Read more
Neurotech International Ltd (NTI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.007x
Based on the latest financial reports, Neurotech International Ltd (NTI) has a cash flow conversion efficiency ratio of -0.007x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-38.33K) by net assets (AU$5.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Neurotech International Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Neurotech International Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Neurotech International Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neurotech International Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Genius Metals Inc
PINK:GNSMF
|
-0.059x |
|
Axteria Group Bhd
KLSE:7120
|
-0.024x |
|
Atlanta Poland SA
WAR:ATP
|
0.164x |
|
Raiden Resources Ltd
AU:RDN
|
-0.066x |
|
Saigon Viendong Technology JSC
VN:SVT
|
N/A |
|
Prakash Steelage Limited
NSE:PRAKASHSTL
|
0.505x |
|
NewHold Investment Corp III Warrants
NASDAQ:NHICW
|
-0.001x |
|
SMRT Holdings Bhd
KLSE:0117
|
0.125x |
Annual Cash Flow Conversion Efficiency for Neurotech International Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Neurotech International Ltd from 2015 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$2.95 Million | AU$-9.02 Million | -3.054x | -690.85% |
| 2024-06-30 | AU$11.90 Million | AU$-4.60 Million | -0.386x | +75.78% |
| 2023-06-30 | AU$3.96 Million | AU$-6.32 Million | -1.594x | +22.85% |
| 2022-06-30 | AU$1.43 Million | AU$-2.96 Million | -2.067x | -244.48% |
| 2021-06-30 | AU$3.86 Million | AU$-2.32 Million | -0.600x | -156.78% |
| 2020-06-30 | AU$-646.29K | AU$-682.83K | 1.057x | +112.36% |
| 2019-06-30 | AU$297.41K | AU$-2.54 Million | -8.551x | -1095.71% |
| 2018-06-30 | AU$4.23 Million | AU$-3.03 Million | -0.715x | +1.59% |
| 2017-06-30 | AU$4.30 Million | AU$-3.12 Million | -0.727x | -1239.04% |
| 2016-06-30 | AU$14.48 Million | AU$-785.79K | -0.054x | +91.75% |
| 2015-12-31 | AU$1.29 Million | AU$-851.21K | -0.657x | -- |